Boston Partners’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-23,550
Closed -$1.09M 710
2023
Q1
$1.09M Hold
23,550
﹤0.01% 513
2022
Q4
$1.09M Buy
23,550
+543
+2% +$24.7K ﹤0.01% 504
2022
Q3
$1.01M Buy
23,007
+382
+2% +$17.6K ﹤0.01% 513
2022
Q2
$959K Buy
22,625
+6,347
+39% +$269K ﹤0.01% 518
2022
Q1
$708K Buy
+16,278
New +$755K ﹤0.01% 588

Other funds holding G

Boston Partners's G Position: Q2 2023 in Review

Boston Partners sold out of Genpact (G) in Q2 2023, closing a stake of 23,550 shares — an estimated $1.09M sold.

Boston Partners first reported a position in G in Q1 2022 and held it in 5 quarters. The position peaked at $1.09M in Q4 2022. 356 funds tracked by Wall St. Rank hold G as of Q2 2023.

  • Boston Partners reported no remaining Genpact position as of Q2 2023 after selling out during the quarter.
  • Boston Partners sold 23,550 Genpact shares in Q2 2023, an estimated $1.09M.
  • Boston Partners first reported a position in Genpact in Q1 2022 and held it in 5 quarters.
  • Boston Partners's Genpact position peaked at $1.09M in Q4 2022.
  • 356 funds tracked by Wall St. Rank held Genpact as of Q2 2023.

Based on Boston Partners's 13F filing for Q2 2023, filed 10 Aug 2023.